A successful Brazilian received a heart transplant while still hospitalized with severe COVID-19 illness. (US News)
People with secondary preventive implantable cardioverting defibrillators have experienced appropriate shocks that rarely occur after 3 months, suggesting that driving restrictions can be relaxed. (Circulation)
COVID-19 patients hospitalized in the UK were more likely to suffer from cardiovascular complications if they were South Asian or black, or had multiple cardiometabolic disorders. (Heart)
Yet another study describes the rarity of myocarditis after COVID-19 vaccination, this time based on nearly 5 million people in Denmark. (BMJ)
Using endomyocardial biopsies, the researchers attempted to identify a cardiac immune signature associated with SARS-CoV-2 infection. (JAMA Cardiology)
Cancer survivors adhering to a healthy lifestyle were more likely to avoid cardiovascular (CV) disease and type 2 diabetes. (JACC: CardioOncology)
There was no clear link between alcohol consumption and incident ventricular arrhythmias in UK biobank data. (Heartbeat)
The learning curve for occlusion of the left atrial appendage was about 30 cases before operators are able to achieve optimal patient outcomes. (JACC: Cardiovascular interventions)
Alirocumab (Praluent), a PCSK9 inhibitor, reduced LDL cholesterol but not major adverse CV events in patients with heart failure (HF) participating in ODYSSEY RESULTS. (European Heart Journal)
Calcium in coronary arteries versus pooled cohort equations: what is the best approach for initiation of statins for primary prevention? (JACC: Cardiovascular Imaging)
Heart failure patients say they are stuck with their HeartWare Ventricular Assist Devices without sufficient support from the government or the manufacturer. (ProPublica)
Janssen announced that rivaroxaban (Xarelto) has been handed over two other FDA indications in pediatric patients: treatment of venous thromboembolism (VTE) and prevention of recurrence of VTE, and thromboprophylaxis after Fontan’s intervention.
Implicit ILR ECG Analyzer, an artificial intelligence algorithm analyzing ECG data from implantable loop recorders, is now FDA 510 (k) approved, according to the company.
The FDA sent an alert stating that the CardioSave Hybrid / Rescue Intra-Aortic Balloon Pump is on Class I recall due to fluid leakage problems that can interrupt circulatory support. The batteries for the device had already been recalled in autumn.
PhaseBio is deactivated pemziviptadil Development Report for pulmonary arterial hypertension, citing supply and enrollment issues due to COVID-19. (FierceBiotech)
triggers spontaneous intracerebral hemorrhage include the flu, coffee consumption, sex and vigorous exercise, according to a study. (Stroke)
Out of 96 randomized trials of acute stroke therapy published from 2013 to 2020, 39 were terminated prematurely – with only a median of 63% of the expected sample size recorded. (Circulation: cardiovascular quality and results)
Approximately 5 years after the start of the ATTR-ACT trial, treatment with tafamidis (Vyndamax) continued to be associated with survival in people with amyloid transthyretin cardiomyopathy. (Circulation: heart failure)
Do self-compassion to prevent women from developing plaque in their carotid arteries? (Health psychology)
COVID-19 has shown that clinical trials can be done remotely and ECG readings reliably transmitted. (Nature Communication)
A former head of CV surgery has used GoFundMe to raise funds to sue the hospital that fired him for not having been vaccinated against the coronavirus. (Philadelphia Investigator)
Last updated on December 21, 2021